Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness

Alzheimer's and Dementia

Volumn 13, Issue 2, 2017, Pages 168-177

  Staubo, Sara C ^a,b   Aakre, Jeremiah A ^a   Vemuri, Prashanthi ^a   Syrjanen, Jeremy A ^a   Mielke, Michelle M ^a   Geda, Yonas E ^a,c   Kremers, Walter K ^a   Machulda, Mary M ^a   Knopman, David S ^a   Petersen, Ronald C ^a   Jack, Clifford R ^a   Roberts, Rosebud O ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c MAYO CLINIC   (United States)

Author keywords

Biomarkers; Cortical thickness; Cross sectional studies; Diet; Fish; Fruit; Legumes; Macronutrients; Magnetic resonance imaging; Nutrition; Structural brain changes; Sugar; Vitamins

Indexed keywords

APOLIPOPROTEIN E4; BETA CAROTENE; CARBOHYDRATE; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TRACE ELEMENT; VITAMIN;

AGED; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE ASSOCIATION; ENTORHINAL CORTEX; FEMALE; FISH; FOOD INTAKE; FRONTAL CORTEX; HUMAN; INFERIOR PARIETAL CORTEX; LEGUME; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; PARIETAL CORTEX; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; SUGAR INTAKE; SUPERIOR PARIETAL LOBULE; TONGUE; BRAIN CORTEX; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; ORGAN SIZE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; DIET, MEDITERRANEAN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICRONUTRIENTS; ORGAN SIZE;

EID: 85013078039     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.06.2359     Document Type: Article

References (48)

1. [1] Scheltens, P., Twisk, J.W., Blesa, R., Scarpini, E., von Arnim, C.A., Bongers, A., et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 31 (2012), 225–236.
2. [2] Kamphuis, P.J., Verhey, F.R., Olde Rikkert, M.G., Twisk, J.W., Swinkels, S.H., Scheltens, P., Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial. J Nutr Health Aging 15 (2011), 720–724.
3. [3] van Wijk, N., Broersen, L.M., de Wilde, M.C., Hageman, R.J., Groenendijk, M., Sijben, J.W., et al. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J Alzheimers Dis 38 (2014), 459–479.
4. [4] Gu, Y., Nieves, J.W., Stern, Y., Luchsinger, J.A., Scarmeas, N., Food combination and Alzheimer disease risk: a protective diet. Arch Neurol 67 (2010), 699–706.
5. [5] Feart, C., Samieri, C., Rondeau, V., Amieva, H., Portet, F., Dartigues, J.F., et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 302 (2009), 638–648.
6. [6] Kesse-Guyot, E., Andreeva, V.A., Lassale, C., Ferry, M., Jeandel, C., Hercberg, S., et al. Mediterranean diet and cognitive function: a French study. J Alzheimers Dis 97 (2013), 369–376.
7. [7] Trichopoulou, A., Costacou, T., Bamia, C., Trichopoulos, D., Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348 (2003), 2599–2608.
8. [8] Morris, M.C., Tangney, C.C., Wang, Y., Sacks, F.M., Bennett, D.A., Aggarwal, N.T., MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement 11 (2015), 1007–1014.
9. [9] Roberts, R.O., Roberts, L.A., Geda, Y.E., Cha, R.H., Pankratz, V.S., O'Connor, H.M., et al. Relative intake of macronutrients impacts risk of mild cognitive impairment or dementia. J Alzheimers Dis 32 (2012), 329–339.
10. [10] Roberts, R.O., Geda, Y.E., Cerhan, J.R., Knopman, D.S., Cha, R.H., Christianson, T.J., et al. Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment. Dement Geriatr Cogn Disord 29 (2010), 413–423.
11. [11] Roberts, R.O., Cerhan, J.R., Geda, Y.E., Knopman, D.S., Cha, R.H., Christianson, T.J., et al. Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging. J Alzheimers Dis 21 (2010), 853–865.
12. [12] Tangney, C.C., Aggarwal, N.T., Li, H., Wilson, R.S., Decarli, C., Evans, D.A., et al. Vitamin B12, cognition, and brain MRI measures: a cross-sectional examination. Neurology 77 (2011), 1276–1282.
13. [13] Bowman, G.L., Silbert, L.C., Howieson, D., Dodge, H.H., Traber, M.G., Frei, B., et al. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 78 (2012), 241–249.
14. [14] Blasko, I., Hinterberger, M., Kemmler, G., Jungwirth, S., Krampla, W., Leitha, T., et al. Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort. J Nutr Health Aging 16 (2012), 687–694.
15. [15] Scarmeas, N., Luchsinger, J.A., Stern, Y., Gu, Y., He, J., DeCarli, C., et al. Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol 69 (2011), 257–268.
16. [16] Mosconi, L., Murray, J., Tsui, W.H., Li, Y., Davies, M., Williams, S., et al. Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. J Prev Alzheimers Dis 1 (2014), 23–32.
17. [17] Gu, Y., Brickman, A.M., Stern, Y., Habeck, C.G., Razlighi, Q.R., Luchsinger, J.A., et al. Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology 85 (2015), 1744–1751.
18. [18] Roberts, R.O., Geda, Y.E., Knopman, D.S., Cha, R.H., Pankratz, V.S., Boeve, B.F., et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 30 (2008), 58–69.
19. [19] St Sauver, J.L., Grossardt, B.R., Yawn, B.P., Melton, L.J.I., Pankratz, J.J., Brue, S.M., et al. Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 41 (2012), 1614–1624.
20. [20] Pfeffer, R.I., Kurosaki, T.T., Harrah, C.H. Jr., Chance, J.M., Filos, S., Measurement of functional activities in older adults in the community. J Gerontol 37 (1982), 323–329.
21. [21] Morris, J.C., The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 (1993), 2412–2414.
22. [22] Petersen, R.C., Mild cognitive impairment as a diagnostic entity. J Intern Med 256 (2004), 183–194.
23. [23] Kokmen, E., Smith, G.E., Petersen, R.C., Tangalos, E., Ivnik, R.C., The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol 48 (1991), 725–728.
24. [24] Ivnik, R.J., Malec, J.F., Smith, G.E., Tangalos, E.G., Petersen, R.C., Kokmen, E., et al. Mayo's older Americans normative studies: WAIS-R norms for ages 56 to 97. Clin Neuropsychol 6 (1992), 1–104.
25. [25] Block, G., Coyle, L.M., Hartman, A.M., Scoppa, S.M., Revision of dietary analysis software for the Health Habits and History Questionnaire. Am J Epidemiol 139 (1994), 1190–1196.
26. [26] Scarmeas, N., Stern, Y., Mayeux, R., Manly, J.J., Schupf, N., Luchsinger, J.A., Mediterranean diet and mild cognitive impairment. Arch Neurol 66 (2009), 216–225.
27. [27] Willett, W., Stampfer, M.J., Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124 (1986), 17–27.
28. [28] Jack, C.R. Jr., Wiste, H.J., Weigand, S.D., Knopman, D.S., Mielke, M.M., Vemuri, P., et al. Different definitions of neurodegeneration produce similar frequencies of amyloid and neurodegeneration biomarker groups by age among cognitively non-impaired individuals. Brain 138 (2015), 3747–3759.
29. [29] Sabuncu, M.R., Desikan, R.S., Sepulcre, J., Yeo, B.T., Liu, H., Schmansky, N.J., et al. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol 68 (2011), 1040–1048.
30. [30] Benzinger, T.L., Blazey, T., Jack, C.R. Jr., Koeppe, R.A., Su, Y., Xiong, C., et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A 110 (2013), E4502–E4509.
31. [31] Holland, D., Brewer, J.B., Hagler, D.J., Fennema-Notestine, C., Dale, A.M., Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A 106 (2009), 20954–20959.
32. [32] Rothman, K.J., No adjustments are needed for multiple comparisons. Epidemiology 1 (1990), 43–46.
33. [33] Witte, A.V., Kerti, L., Hermannstadter, H.M., Fiebach, J.B., Schreiber, S.J., Schuchardt, J.P., et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 24 (2014), 3059–3068.
34. [34] Köbe, T., Witte, A.V., Schnelle, A., Lesemann, A., Fabian, S., Tesky, V.A., et al. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage 131 (2016), 226–238.
35. [35] Alosco, M.L., Gunstad, J., Xu, X., Clark, U.S., Labbe, D.R., Riskin-Jones, H.H., et al. The impact of hypertension on cerebral perfusion and cortical thickness in older adults. J Am Soc Hypertens 8 (2014), 561–570.
36. [36] van Velsen, E.F., Vernooij, M.W., Vrooman, H.A., van der Lugt, A., Breteler, M.M., Hofman, A., et al. Brain cortical thickness in the general elderly population: the Rotterdam Scan Study. Neurosci Lett 550 (2013), 189–194.
37. [37] Scarmeas, N., Stern, Y., Tang, M.X., Mayeux, R., Luchsinger, J.A., Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59 (2006), 912–921.
38. [38] Schaefer, E.J., Bongard, V., Beiser, A.S., Lamon-Fava, S., Robins, S.J., Au, R., et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63 (2006), 1545–1550.
39. [39] Beydoun, M.A., Kaufman, J.S., Satia, J.A., Rosamond, W., Folsom, A.R., Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 85 (2007), 1103–1111.
40. [40] Jerneren, F., Elshorbagy, A.K., Oulhaj, A., Smith, S.M., Refsum, H., Smith, A.D., Brain atrophy in cognitively impaired elderly: the importance of long-chain omega-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr 102 (2015), 215–221.
41. [41] Engelhart, M.J., Geerlings, M.I., Ruitenberg, A., van Swieten, J.C., Hofman, A., Witteman, J.C., et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287 (2002), 3223–3229.
42. [42] Psaltopoulou, T., Kyrozis, A., Stathopoulos, P., Trichopoulos, D., Vassilopoulos, D., Trichopoulou, A., Diet, physical activity and cognitive impairment among elders: the EPIC-Greece cohort (European Prospective Investigation into Cancer and Nutrition). Public Health Nutr 11 (2008), 1054–1062.
43. [43] Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Wilson, R.S., Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 62 (2004), 1573–1579.
44. [44] Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, D.A., Aggarwal, N., et al. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60 (2003), 194–200.
45. [45] Kalmijn, S., Launer, L.J., Ott, A., Witteman, J.C., Hofman, A., Breteler, M.M., Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42 (1997), 776–782.
46. [46] McNeill, S.H., Inclusion of red meat in healthful dietary patterns. Meat Sci 98 (2014), 452–460.
47. [47] Barberger-Gateau, P., Letenneur, L., Deschamps, V., Peres, K., Dartigues, J.F., Renaud, S., Fish, meat, and risk of dementia: cohort study. BMJ 325 (2002), 932–933.
48. [48] Shahar, D., Fraser, D., Shai, I., Vardi, H., Development of a food frequency questionnaire (FFQ) for an elderly population based on a population survey. J Nutr 133 (2003), 3625–3629.